Home
General Information to Patients
ALL
AML
Anus
Bladder/urothelial
Brain
Breast
Cervix
CLL
CML
Colon and Rectum
GIST
Hairy Cell Leuk.
Head and Neck
Hemato/Graft
Hepatic Ducts
Hodgkin
Kidney
Liver
Melanoma
Mesothelioma
MPN
MDS
Myeloma
Neuroendocr. T
NSCLC
NHL
Oesophagus
Ovary
Pancreas
Prostate
Sarcoma
Skin
SCLC
Solid Tumors
Stomach
Testis
Thyroid
Uterine Sarcoma
Uterus Lining
Clinical Trials
View all
Search
Videos for patients
Oral therapy
Chemo & Immunotherapy
Immunotherapy (professionals)
Guidelines : Management of Toxicities
Administration Guides and Advice to patients
Administrative Tools
Recherche
Home
Hodgkin's Disease
Treatment Regimens
Hodgkin's Disease
Hodgkin's Disease
TREATMENT REGIMENS
Initial treatment
ABVD
Refractory disease
GDP
ESHAP
ICE
DHAP
Brentuximab vedotin
Consolidation therapy after autologous-stem cell transplantation in patients with risk for relapse
Groupe d'étude en oncologie du Québec